GPR43 protects human A16 cardiomyocytes against hypoxia/reoxygenation injury by regulating nesfatin1.

BACKGROUND The purpose of this study is to investigate the regulatory role of G coupled-protein receptor 43 (GPR43) during myocardial ischemia/reperfusion (I/R) injury and to explore the relevant molecular mechanism. MATERIALS AND METHODS AC16 hypoxia/reoxygenation (H/R) model was established to simulate I/R injury in vitro. Gain- and loss-of-function experiments were conducted to regulate GPR43 or nesfatin1 expression. Cell viability and apoptosis was examined adopting CCK-8 and TUNEL assays. Commercial kits were applied for detecting ROS and inflammatory cytokines. Quantitative real-time PCR (qRT-PCR) and western blotting were conducted to measure the expression level of critical genes and proteins. RESULTS GPR43 was downregulated in H/R-mediated AC16 cells. GPR43 overexpression or the GPR43 agonist greatly inhibited H/R-induced cell viability loss, cell apoptosis, and excessive production of ROS and pro-inflammatory cytokines in AC16 cardiomyocytes. Co-immunoprecipitation (Co-IP) assay identified an interaction between GPR43 and nesfatin1, and GPR43 could positively regulate nesfatin1. In addition, the protective role of GPR43 against H/R injury was partly abolished upon nesfatin1 knockdown. Eventually, GPR43 could inhibit H/R-stimulated JNK/P38 MAPK signaling in AC16 cells, which was also hindered by nesfatin1 knockdown. CONCLUSIONS Our findings demonstrated the protective role of GPR43 against H/R-mediated cardiomyocytes injury through up-regulating nesfatin1, providing a novel target for the prevention and treatment of myocardial I/R injury.

[1]  Xuan Jiang,et al.  Acetate suppresses myocardial contraction via the short-chain fatty acid receptor GPR43 , 2022, Frontiers in Physiology.

[2]  Wei Li,et al.  PCSK9 Knockdown Can Improve Myocardial Ischemia/Reperfusion Injury by Inhibiting Autophagy , 2022, Cardiovascular Toxicology.

[3]  Shuang He,et al.  CXCR1 and its downstream NF-κB inflammation signaling pathway as a key target of Guanxinning injection for myocardial ischemia/reperfusion injury , 2022, Frontiers in Immunology.

[4]  Qiumin Xu,et al.  Regulation of inflammation and apoptosis by GPR43 via JNK/ELK1 in acute lung injury , 2022, Inflammation Research.

[5]  A. Lymperopoulos,et al.  Short-Chain Fatty Acid Receptors and Cardiovascular Function , 2022, International journal of molecular sciences.

[6]  Yayi Hou,et al.  Bornlisy Attenuates Colitis-Associated Colorectal Cancer via Inhibiting GPR43-Mediated Glycolysis , 2021, Frontiers in Nutrition.

[7]  Wei Liu,et al.  LncRNA LSINCT5/miR-222 regulates myocardial ischemia‑reperfusion injury through PI3K/AKT pathway , 2021, Journal of Thrombosis and Thrombolysis.

[8]  Sung Goo Park,et al.  Novel GPR43 Agonists Exert an Anti-Inflammatory Effect in a Colitis Model , 2021, Biomolecules & therapeutics.

[9]  Yi Qu,et al.  Role of Oxidative Stress in Reperfusion following Myocardial Ischemia and Its Treatments , 2021, Oxidative medicine and cellular longevity.

[10]  H. Yin,et al.  Nesfatin‐1 inhibits myocardial ischaemia/reperfusion injury through activating Akt/ERK pathway‐dependent attenuation of endoplasmic reticulum stress , 2021, Journal of cellular and molecular medicine.

[11]  Chaoqun Nie,et al.  Hydrogen gas inhalation alleviates myocardial ischemia-reperfusion injury by the inhibition of oxidative stress and NLRP3-mediated pyroptosis in rats. , 2021, Life sciences.

[12]  J. Kou,et al.  Mechanisms Dissection of the combination GRS derived from ShengMai preparations for the treatment of myocardial ischemia/reperfusion injury. , 2020, Journal of ethnopharmacology.

[13]  Yayun Xu,et al.  Antioxidant, Anti-Inflammatory and Anti-Apoptotic Activities of Nesfatin-1: A Review , 2020, Journal of inflammation research.

[14]  K. Rakhshan,et al.  Nesfatin-1 attenuates injury in a rat model of myocardial infarction by targeting autophagy, inflammation, and apoptosis , 2020, Archives of physiology and biochemistry.

[15]  T. Yousuf,et al.  Natural disasters and acute myocardial infarction. , 2020, Progress in cardiovascular diseases.

[16]  T. Pasqua,et al.  Nesfatin-1 in cardiovascular orchestration: From bench to bedside. , 2020, Pharmacological research.

[17]  P. Zhou,et al.  Activation of GPR43 suppresses TNF-α-induced inflammatory response in human fibroblast-like synoviocytes. , 2020, Archives of biochemistry and biophysics.

[18]  Weiwei Chen,et al.  Low Expression of FFAR2 in Peripheral White Blood Cells May Be a Genetic Marker for Early Diagnosis of Acute Myocardial Infarction , 2020, Cardiology research and practice.

[19]  Guibo Sun,et al.  Shuxuening injection protects against myocardial ischemia-reperfusion injury through reducing oxidative stress, inflammation and thrombosis. , 2019, Annals of translational medicine.

[20]  Q. Wang,et al.  Quantitative proteomics reveal the alterations in the spinal cord after myocardial ischemia-reperfusion injury in rats , 2019, International journal of molecular medicine.

[21]  A. Blanco,et al.  Nesfatin-1 Regulates Feeding, Glucosensing and Lipid Metabolism in Rainbow Trout , 2018, Front. Endocrinol..

[22]  Eric L. Johnson,et al.  Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018 , 2018, Annals of Internal Medicine.

[23]  Bao-Long Wang,et al.  Plasma nesfatin-1 level is associated with severity of depression in Chinese depressive patients , 2018, BMC Psychiatry.

[24]  N. Chattipakorn,et al.  Roles of mitochondrial dynamics modulators in cardiac ischaemia/reperfusion injury , 2017, Journal of cellular and molecular medicine.

[25]  E. Gao,et al.  Melatonin ameliorates myocardial ischemia reperfusion injury through SIRT3‐dependent regulation of oxidative stress and apoptosis , 2017, Journal of pineal research.

[26]  A. Alizadeh,et al.  Reactive oxygen species-mediated cardiac-reperfusion injury: Mechanisms and therapies. , 2016, Life sciences.

[27]  A. Stengel,et al.  Role of Brain NUCB2/nesfatin-1 in the Stress-induced Modulation of Gastrointestinal Functions , 2016, Current neuropharmacology.

[28]  C. White,et al.  High-density lipoprotein, mitochondrial dysfunction and cell survival mechanisms. , 2016, Chemistry and physics of lipids.

[29]  H. Randeva,et al.  Short-Chain Fatty Acid Acetate Stimulates Adipogenesis and Mitochondrial Biogenesis via GPR43 in Brown Adipocytes. , 2016, Endocrinology.

[30]  C. Mackay,et al.  GPR43 – A Prototypic Metabolite Sensor Linking Metabolic and Inflammatory Diseases , 2015, Trends in Endocrinology & Metabolism.

[31]  M. Mulholland,et al.  Peripheral Effects of Nesfatin-1 on Glucose Homeostasis , 2013, PloS one.

[32]  N. Delzenne,et al.  GPR43/FFA2: physiopathological relevance and therapeutic prospects. , 2013, TIPS - Trends in Pharmacological Sciences.

[33]  Joseph A. Hill,et al.  Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. , 2010, The American journal of cardiology.

[34]  M. Mori,et al.  Identification of nesfatin-1 as a satiety molecule in the hypothalamus , 2006, Nature.

[35]  Zhi-Qing Zhao.  Oxidative stress-elicited myocardial apoptosis during reperfusion. , 2004, Current opinion in pharmacology.

[36]  T. Yokota,et al.  LSSIG is a novel murine leukocyte-specific GPCR that is induced by the activation of STAT3. , 2003, Blood.

[37]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .